SCHEMBL8979922

SCHEMBL8979922

O=S(=O)(NCCCCN1CCc2ccccc2C1)c1ccc(F)cc1

nearest known ligand 0.82

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 12/20 0.82
HTR6 P50406 2/20 0.64
HTR1A P08908 3/20 0.58
DRD2 P14416 3/20 0.58
DRD3 P35462 3/20 0.58
HTR2A P28223 2/20 0.58
HRH1 P35367 2/20 0.58
HTR2B P41595 2/20 0.58
SLC6A4 P31645 1/20 0.58
DRD4 P21917 1/20 0.57
ADRA1D P25100 1/20 0.57
ADRA1A P35348 1/20 0.57
ADRA1B P35368 1/20 0.57
CCR3 P51677 1/20 0.56
HTR5A P47898 1/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
PKM P14618 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8980036 0.99 HTR7 (0.80) HTR7HTR6HTR1ADRD2DRD3
Hydrochloric Acid SCHEMBL4228329 0.99 HTR7 (0.80) HTR7HTR6HTR1ADRD2DRD3
Hydrochloric Acid SCHEMBL4232359 0.98 HTR7 (0.79) HTR7HTR6HTR1ADRD2DRD3
SCHEMBL10035542 0.96 HTR7 (0.82) HTR7HTR6HTR1ADRD2DRD3
Hydrochloric Acid SCHEMBL2136791 0.95 HTR7 (0.80) HTR7HTR6HTR1ADRD2DRD3
SCHEMBL8979759 0.90 HTR7 (1.00) HTR7HTR6HTR1AHTR2A
Hydrochloric Acid SCHEMBL4224263 0.89 HTR7 (0.97) HTR7HTR6HTR1AHTR2A
SCHEMBL8980016 0.89 HTR7 (0.97) HTR7HTR6HTR1AHTR2AALDH1A1
SCHEMBL8980638 0.88 HTR7 (0.82) HTR7HTR6HTR1ADRD2DRD3
SCHEMBL8979883 0.88 HTR7 (0.82) HTR7HTR6HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188115-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-05-29 US disclosed
US-8188115-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-05-29 US disclosed
US-20090163542-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-06-25 US disclosed
US-20090163542-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-06-25 US disclosed
US-7211585-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-05-01 US disclosed
US-7211585-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163542-A1 5-ht7 receptor antagonists HTR7, HTR1A, HTR5A HTR7 1/4885HTR6 7/4885HTR1A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.